Liu K. Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Liu K. Yang has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Chi-Hung Shu
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, USA
3 shared publications - David Seong
Department of Anesthesiology, Perioperative, and Pain Medicine, Stanford School of Medicine, Stanford, CA, USA
3 shared publications - Marc Ghanem
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, USA
3 shared publications - Nima Aghaeepour
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Palo Alto, CA, United States
3 shared publications - Philip Chung
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, USA
3 shared publications - Boris Oskotsky
Bakar Computational Health Sciences Institute, University of California, San Francisco, CA, USA
2 shared publications
Latest Publications
- Open Access
Blood-brain barrier dysfunction predicts cognitive trajectory after ischemic stroke
Ischemic stroke doubles the risk of dementia. 1–4 Stroke severity and location affect cognition early, 5,6 but late dementia risk is not related to infarct characteristics, nor is it reduced by preventing additional strokes, 3,6,7 and its mechanism is unknown. We identified a plasma proteomic signature of chronic stroke that was consistent with blood-brain barrier (BBB) dysfunction, including a 58% decrease in plasma levels of platelet-derived growth factor B and downregulation of its pathway compared to healthy controls. During 2 years of follow-up, the stroke-specific proteome was accentuated in stroke survivors who subsequently declined in the processing speed/executive function cognitive domain. To test BBB function, we performed dynamic contrast-enhanced MRI 6-9 months after stroke in an additional cohort and found 1.7-fold higher whole brain BBB leakage compared to controls. Finally, we compared autopsy tissue from people with infarcts and dementia at death to those with infarcts and no dementia. Those who died with dementia had dramatic loss of vascular mural cell coverage compared to those without dementia (median 0.7% vs. 27%). Thus, our proteomic, functional, and structural data implicate chronic BBB dysfunction in cognitive decline late after stroke, revealing potential proteomic and imaging biomarkers and, importantly, a novel target for intervention.
Open AccessBlood-brain barrier dysfunction predicts cognitive trajectory after ischemic stroke
Ischemic stroke doubles the risk of dementia. 1–4 Stroke severity and location affect cognition early, 5,6 but late dementia risk is not related to infarct characteristics, nor is it reduced by preventing additional strokes, 3,6,7 and its mechanism is unknown. We identified a plasma proteomic signature of chronic stroke that was consistent with blood-brain barrier (BBB) dysfunction, including a 58% decrease in plasma levels of platelet-derived growth factor B and downregulation of its pathway compared to healthy controls. During 2 years of follow-up, the stroke-specific proteome was accentuated in stroke survivors who subsequently declined in the processing speed/executive function cognitive domain. To test BBB function, we performed dynamic contrast-enhanced MRI 6-9 months after stroke in an additional cohort and found 1.7-fold higher whole brain BBB leakage compared to controls. Finally, we compared autopsy tissue from people with infarcts and dementia at death to those with infarcts and no dementia. Those who died with dementia had dramatic loss of vascular mural cell coverage compared to those without dementia (median 0.7% vs. 27%). Thus, our proteomic, functional, and structural data implicate chronic BBB dysfunction in cognitive decline late after stroke, revealing potential proteomic and imaging biomarkers and, importantly, a novel target for intervention.
- Open Access
- 9 April 2025
- Published by Springer Nature in Nature Medicine
- Vol. 31 (6) , 2070
Author Correction: AI-guided precision parenteral nutrition for neonatal intensive care units
- 9 April 2025
- Published by Springer Nature in Nature Medicine
- Vol. 31 (6) , 2070
Open AccessAuthor Correction: AI-guided precision parenteral nutrition for neonatal intensive care units
- Top Cited PapersOpen Access
- 25 March 2025
- Published by Springer Nature in Nature Medicine
- Vol. 31 (6) , 1882-1894
AI-guided precision parenteral nutrition for neonatal intensive care units
One in ten neonates are admitted to neonatal intensive care units, highlighting the need for precise interventions. However, the application of artificial intelligence (AI) in guiding neonatal care remains underexplored. Total parenteral nutrition (TPN) is a life-saving treatment for preterm neonates; however, implementation of the therapy in its current form is subjective, error-prone and resource-consuming. Here, we developed TPN2.0—a data-driven approach that optimizes and standardizes TPN using information collected routinely in electronic health records. We assembled a decade of TPN compositions (79,790 orders; 5,913 patients) at Stanford to train TPN2.0. In addition to internal validation, we also validated our model in an external cohort (63,273 orders; 3,417 patients) from a second hospital. Our algorithm identified 15 TPN formulas that can enable a precision-medicine approach (Pearson’s R = 0.94 compared to experts), increasing safety and potentially reducing cost. A blinded study (n = 192) revealed that physicians rated TPN2.0 higher than current best practice. In patients with high disagreement between the actual prescriptions and TPN2.0, standard prescriptions were associated with increased morbidities (for example, odds ratio = 3.33; P value = 0.0007 for necrotizing enterocolitis), while TPN2.0 recommendations were linked to reduced risk. Finally, we demonstrated that TPN2.0 employing a transformer architecture enabled guideline-adhering, physician-in-the-loop recommendations that allow collaboration between the care team and AI.
- 25 March 2025
- Published by Springer Nature in Nature Medicine
- Vol. 31 (6) , 1882-1894
Top Cited PapersOpen AccessAI-guided precision parenteral nutrition for neonatal intensive care units
One in ten neonates are admitted to neonatal intensive care units, highlighting the need for precise interventions. However, the application of artificial intelligence (AI) in guiding neonatal care remains underexplored. Total parenteral nutrition (TPN) is a life-saving treatment for preterm neonates; however, implementation of the therapy in its current form is subjective, error-prone and resource-consuming. Here, we developed TPN2.0—a data-driven approach that optimizes and standardizes TPN using information collected routinely in electronic health records. We assembled a decade of TPN compositions (79,790 orders; 5,913 patients) at Stanford to train TPN2.0. In addition to internal validation, we also validated our model in an external cohort (63,273 orders; 3,417 patients) from a second hospital. Our algorithm identified 15 TPN formulas that can enable a precision-medicine approach (Pearson’s R = 0.94 compared to experts), increasing safety and potentially reducing cost. A blinded study (n = 192) revealed that physicians rated TPN2.0 higher than current best practice. In patients with high disagreement between the actual prescriptions and TPN2.0, standard prescriptions were associated with increased morbidities (for example, odds ratio = 3.33; P value = 0.0007 for necrotizing enterocolitis), while TPN2.0 recommendations were linked to reduced risk. Finally, we demonstrated that TPN2.0 employing a transformer architecture enabled guideline-adhering, physician-in-the-loop recommendations that allow collaboration between the care team and AI.
- Open Access
- 17 October 2024
- Published by BMJ in BMJ Neurology Open
- Vol. 6 (2) , e000804
Review of theories into the pathogenesis of normal pressure hydrocephalus
Normal pressure hydrocephalus (NPH) represents a unique form of hydrocephalus characterised by the paradox of ventriculomegaly without significant elevations in intracranial pressure, with the clinical triad of gait instability, cognitive impairment, and urinary incontinence. A myriad of neurobiological correlates have been implicated in its pathophysiology. We review the literature to provide an up-to-date, narrative review of the proposed mechanisms underlying the pathophysiology of NPH, proposing a holistic framework through which to understand the condition. We conducted a narrative review of the literature on NPH, assessing the various mechanisms underlying its pathophysiology and clinical presentation. NPH represents a unique form of hydrocephalus manifesting as a disorder of the cerebral vasculature, characterised by arteriosclerosis and reduced intracranial elastance. There are multiple mechanisms underlying its pathophysiology, which include windkessel impairment causing redistribution of intracranial pulsatility from the subarachnoid space to the ventricles, reductions in cerebral blood flow, impaired glymphatic clearance, reduced blood–brain barrier integrity and alterations in venous haemodynamics. Moreover, NPH shares similar clinical features and pathological mechanisms as other neurodegenerative conditions such as Alzheimer’s disease and vascular dementia. The severity of each respective mechanism of pathophysiology can lead a patient to develop one condition versus another. Analysing NPH as a disorder of the cerebral vasculature, glymphatics, and most of all, the distribution of intracranial pulsatility, provides a novel framework through which to understand and manage this condition, one which requires further investigation.
- 17 October 2024
- Published by BMJ in BMJ Neurology Open
- Vol. 6 (2) , e000804
Open AccessReview of theories into the pathogenesis of normal pressure hydrocephalus
Normal pressure hydrocephalus (NPH) represents a unique form of hydrocephalus characterised by the paradox of ventriculomegaly without significant elevations in intracranial pressure, with the clinical triad of gait instability, cognitive impairment, and urinary incontinence. A myriad of neurobiological correlates have been implicated in its pathophysiology. We review the literature to provide an up-to-date, narrative review of the proposed mechanisms underlying the pathophysiology of NPH, proposing a holistic framework through which to understand the condition. We conducted a narrative review of the literature on NPH, assessing the various mechanisms underlying its pathophysiology and clinical presentation. NPH represents a unique form of hydrocephalus manifesting as a disorder of the cerebral vasculature, characterised by arteriosclerosis and reduced intracranial elastance. There are multiple mechanisms underlying its pathophysiology, which include windkessel impairment causing redistribution of intracranial pulsatility from the subarachnoid space to the ventricles, reductions in cerebral blood flow, impaired glymphatic clearance, reduced blood–brain barrier integrity and alterations in venous haemodynamics. Moreover, NPH shares similar clinical features and pathological mechanisms as other neurodegenerative conditions such as Alzheimer’s disease and vascular dementia. The severity of each respective mechanism of pathophysiology can lead a patient to develop one condition versus another. Analysing NPH as a disorder of the cerebral vasculature, glymphatics, and most of all, the distribution of intracranial pulsatility, provides a novel framework through which to understand and manage this condition, one which requires further investigation.
- 6 June 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 5579-5583
Particle Gibbs Sampling for Regime-Switching State-Space Models
Regime-switching state-space models (RS-SSMs) are an important class of statistical models that can be used to represent real-world phenomena. Unlike regular state-space models, RS-SSMs allow for dynamic uncertainty in the state transition and observations distributions, making them much more expressive. Unfortunately, there are no existing Bayesian inference techniques for joint estimation of regimes, states, and model parameters in generic RS-SSMs. In this work, we develop a particle Gibbs sampling algorithm for Bayesian learning in RS-SSMs. We demonstrate the proposed inference approach on a synthetic data experiment related to an ecological application, where the goal is in estimating the abundance and demographic rates of penguins in the Antarctic.
- 6 June 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 5579-5583
Particle Gibbs Sampling for Regime-Switching State-Space Models
Regime-switching state-space models (RS-SSMs) are an important class of statistical models that can be used to represent real-world phenomena. Unlike regular state-space models, RS-SSMs allow for dynamic uncertainty in the state transition and observations distributions, making them much more expressive. Unfortunately, there are no existing Bayesian inference techniques for joint estimation of regimes, states, and model parameters in generic RS-SSMs. In this work, we develop a particle Gibbs sampling algorithm for Bayesian learning in RS-SSMs. We demonstrate the proposed inference approach on a synthetic data experiment related to an ecological application, where the goal is in estimating the abundance and demographic rates of penguins in the Antarctic.
- 4 April 2020
- Published by Springer Nature
- p. 2251-2258
Low-Complexity Channel Estimation Method Based on ISSOR-PCG for Massive MIMO Systems
- 4 April 2020
- Published by Springer Nature
- p. 2251-2258
Low-Complexity Channel Estimation Method Based on ISSOR-PCG for Massive MIMO Systems
- Open Access
- 1 January 2019
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 17 (1) , 165-176
Increased Genetic Instability and Accelerated Progression of Colitis-Associated Colorectal Cancer through Intestinal Epithelium–specific Deletion ofKlf4
Krüppel-like factor 4 (KLF4), a zinc finger transcription factor, regulates homeostasis of the intestinal epithelium. Previously, it was reported that KLF4 functions as a tumor suppressor in colorectal cancer. Here, evidence demonstrates that KLF4 mitigates the development and progression of colitis-associated colorectal cancer (CAC) in a murine model. Mice with intestinal epithelium–specific deletion of Klf4 (Klf4ΔIS) and control mice (Klf4fl/fl) were used to explore the role of KLF4 in the development of azoxymethane (AOM) and dextran sodium sulfate (DSS)-induced CAC. Upon AOM and DSS treatment, KLF4 expression was progressively lost in colonic tissues of Klf4fl/fl mice during tumor development. Klf4ΔIS mice treated with AOM/DSS developed significantly more adenomatous polyps and carcinomas in situ in comparison with treated Klf4fl/fl mice. Adenomatous polyps, but not normal-appearing mucosa, from colonic tissues of treated Klf4ΔIS mice contained a significantly increased number of mitotic cells with more than 2 centrosomes relative to treated control mice. KLF4 and p53 colocalize to the centrosomes in mouse embryonic fibroblasts (MEF). Absence of KLF4 in Klf4−/− MEFs inhibits and its overexpression restores p53 localization to the centrosomes in Klf4−/− MEFs.Implications: Taken together, these results indicate that KLF4 plays a protective role against progression of CAC by guarding against genetic instability.
- 1 January 2019
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 17 (1) , 165-176
Open AccessIncreased Genetic Instability and Accelerated Progression of Colitis-Associated Colorectal Cancer through Intestinal Epithelium–specific Deletion ofKlf4
Krüppel-like factor 4 (KLF4), a zinc finger transcription factor, regulates homeostasis of the intestinal epithelium. Previously, it was reported that KLF4 functions as a tumor suppressor in colorectal cancer. Here, evidence demonstrates that KLF4 mitigates the development and progression of colitis-associated colorectal cancer (CAC) in a murine model. Mice with intestinal epithelium–specific deletion of Klf4 (Klf4ΔIS) and control mice (Klf4fl/fl) were used to explore the role of KLF4 in the development of azoxymethane (AOM) and dextran sodium sulfate (DSS)-induced CAC. Upon AOM and DSS treatment, KLF4 expression was progressively lost in colonic tissues of Klf4fl/fl mice during tumor development. Klf4ΔIS mice treated with AOM/DSS developed significantly more adenomatous polyps and carcinomas in situ in comparison with treated Klf4fl/fl mice. Adenomatous polyps, but not normal-appearing mucosa, from colonic tissues of treated Klf4ΔIS mice contained a significantly increased number of mitotic cells with more than 2 centrosomes relative to treated control mice. KLF4 and p53 colocalize to the centrosomes in mouse embryonic fibroblasts (MEF). Absence of KLF4 in Klf4−/− MEFs inhibits and its overexpression restores p53 localization to the centrosomes in Klf4−/− MEFs.Implications: Taken together, these results indicate that KLF4 plays a protective role against progression of CAC by guarding against genetic instability.